We are live on ! Find out more
CLB icon

Core Laboratories

178 hedge funds and large institutions have $1.16B invested in Core Laboratories in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

296% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $255K

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

9% more funds holding

Funds holding: 164178 (+14)

2% more capital invested

Capital invested by funds: $1.13B → $1.16B (+$26.3M)

0.88% less ownership

Funds ownership: 104.51%103.64% (-0.88%)

15% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 66

Holders
178
Holders Change
+14
Holders Change %
+8.54%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
56
Reduced
66
Closed
8
Calls
$1.01M
Puts
$255K
Net Calls
+$755K
Net Calls Change
-$568K
Name Holding Trade Value Shares
Change
Change in
Stake
SI
26
Scout Investments
Missouri
$6.68M -$204K -8,305 -3%
Bank of America
27
Bank of America
North Carolina
$6.62M -$2.44M -99,282 -26%
Principal Financial Group
28
Principal Financial Group
Iowa
$6.02M -$351K -14,311 -5%
Citadel Advisors
29
Citadel Advisors
Florida
$5.88M +$1.11M +45,389 +23%
ACM
30
Advisors Capital Management
New Jersey
$5.53M -$5.3K -216 -0.1%
Goldman Sachs
31
Goldman Sachs
New York
$5.37M +$2.7M +109,815 +97%
SIC
32
Schwartz Investment Counsel
Michigan
$4.9M
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$4.83M +$2.42M +98,413 +96%
Wells Fargo
34
Wells Fargo
California
$4.19M +$489K +19,924 +13%
CIM
35
Confluence Investment Management
Missouri
$4.05M -$547K -22,278 -12%
CWM
36
Congress Wealth Management
Massachusetts
$3.68M +$301K +12,264 +9%
HKAM
37
Horizon Kinetics Asset Management
New York
$3.53M
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$3.44M +$90.9K +3,703 +3%
N
39
Nuveen
North Carolina
$3.4M +$151K +6,134 +5%
GJL
40
Gendell Jeffrey L
$2.88M +$1.1M +44,953 +60%
Fidelity Investments
41
Fidelity Investments
Massachusetts
$2.65M -$1.15M -46,832 -30%
State of New Jersey Common Pension Fund D
42
State of New Jersey Common Pension Fund D
New Jersey
$2.5M +$2.56M +104,186 New
Swiss National Bank
43
Swiss National Bank
Switzerland
$2.46M +$24.5K +1,000 +1%
CS
44
Credit Suisse
Switzerland
$2.16M -$510K -20,767 -19%
Russell Investments Group
45
Russell Investments Group
United Kingdom
$1.82M +$1.84M +74,976 +9,944%
MC
46
Moors & Cabot
Massachusetts
$1.78M -$39.9K -1,625 -2%
CCIA
47
Campbell & Co Investment Adviser
Maryland
$1.77M +$1.81M +73,684 New
UBS AM
48
UBS AM
Illinois
$1.7M +$276K +11,234 +19%
OAM
49
Oppenheimer Asset Management
New York
$1.62M -$171K -6,965 -9%
MAA
50
Mraz Amerine & Associates
California
$1.6M -$23.3K -950 -1%

CLB Hedge Fund Activity: Q3 2023 in Review

178 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2023, worth a combined $1.16B — up 2.3% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CLB positions and 8 closed out — a net gain of 14 holders — while 56 added to existing stakes and 66 trimmed.

The largest buyer was LMR Partners, opening a new position worth an estimated $10.7M. The largest seller was Fred Alger Management, cutting an estimated $34.4M.

  • 178 institutional investors held Core Laboratories (CLB) as of Q3 2023, up from 164 in Q2 2023.
  • Funds reported $1.16B of Core Laboratories stock for Q3 2023, up 2.3% quarter-over-quarter.
  • 22 funds opened new Core Laboratories positions in Q3 2023 and 8 closed out, a net change of +14 holders.
  • The largest Core Laboratories buyer in Q3 2023 was LMR Partners, an estimated $10.7M added.
  • The largest Core Laboratories seller in Q3 2023 was Fred Alger Management, an estimated $34.4M sold.

Based on aggregated 13F filings for Q3 2023.